Navigation Links
L.S.E. (Barcelona) anuncia la primera financiación del antiplaquetario NmC por inversores españoles y suizos
Date:11/5/2012

BARCELONA, November 5, 2012 /PRNewswire/ --

- Life Sciences Entrepreneurs S.L.U. anuncia la primera financiación del antiplaquetario nmc por inversores españoles y suizos -

Life Science Entrepreneurs S.L.U., una empresa dedicada al desarrollo incipiente de proyectos de gran riesgo y muy alto beneficio, anuncia hoy la primera inversión para el medicamento candidato antiplaquetario denominado NmC.

Algunos inversores privados de Barcelona, Ginebra y Basilea, todos activos en las aplicaciones médicas de ciencias de la vida, han financiado los ensayos necesarios para confirmar la seguridad y eficacia del medicamento cardiovascular NmC.

"NmC puede prevenir incidentes cardiovasculares gracias a su forma exclusiva de diluir la sangre de los pacientes en riesgo", ha declarado François Arcand, Presidente de Life Science  Entrepreneurs S.L.U.. "El medicamento interesa a los expertos del sector porque su novedoso mecanismo de acción podría distinguirlo de antitrombóticos como Plavix ®, el estándar actual, o el recientemente incorporado Eliquis ®".

Los derechos sobre la molécula se han obtenido de una universidad extranjera. A principios de 2013, Life Science Entrepreneurs S.L.U. recaudará 2 millones de euros de inversores españoles y extranjeros para llevar a cabo un conjunto reglamentario y completo de ensayos preclínicos.

Acerca de ...

Life Science Entrepreneurs S.L.U. desarrolla descubrimientos científicos hasta la realización de una prueba de concepto viable, cuando las tecnologías probadas son adquiridas por organizaciones especializadas y de gran poder económico.  Para obtener más información, consulte http://www.LifSciE.com

 

Català : http://www.lifscie.com/cat/en/enemce/
English : http://www.lifscie.com/en/enemce/
Français : http://www.lifscie.com/fr/enemce/



'/>"/>
SOURCE Life Science Entrepreneurs S.L.U.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
Breaking Medicine Technology:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):